Table 1.
Compound | Action | LX-2 | aLMF | HSEC |
---|---|---|---|---|
Semicarbazide | SSAO inhibitor | X | X | X |
Methylamine | SSAO substrate | X | X | X |
Brefeldin A | Golgi/endosome inhibitor | Majority of GFP signal retained in Golgi | ||
Monensin | Golgi inhibitor | X | X | X |
Jasplakinolide | Actin inhibitor | X | Minor changes in distribution of GFP signal | |
Cytochalasin D | Actin inhibitor | GFP and VAP-1 distribution largely unaffected relative to cell shape. Association with cell protrusions more pronounced | ||
Nocodzaole | Microtubule inhibitor | X | Minor changes in distribution of GFP signal | |
Marimastat | Metalloproteinase inhibitor | X | X | X |
Bafilomycin A1 | H + -ATPase inhibitor | Induced co-localization of GFP and anti-VAP-1 signal |
“X” denotes no gross effect on distribution of GFP signal